Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 17 Jan 2024 07:30 CET |
INTERVEST OFF-WARE | Intervest Offices & Warehouses SA: Communiqué de presse – Persbericht - Press release: announcement of publication of prospectus and response memorandum regarding voluntary and conditional takeover offer in cash by TPG | 35102030 Office REITs | Takeover bids |
| 17 Jan 2024 07:30 CET |
INTERVEST OFF-WARE | Intervest Offices & Warehouses NV: Persbericht – Communiqué de presse – Press release: announcement of publication of prospectus and response memorandum regarding voluntary and conditional takeover offer in cash by TPG | 35102030 Office REITs | Takeover bids |
| 16 Jan 2024 22:01 CET |
CELYAD ONCOLOGY | Celyad Oncology fait le point sur les activités du quatrième trimestre 2023 et présente ses perspectives pour 2024 | 20103010 Biotechnology | Corporate life |
| 16 Jan 2024 22:01 CET |
CELYAD ONCOLOGY | Celyad Oncology Provides Fourth Quarter 2023 Business Update and 2024 Outlook | 20103010 Biotechnology | Corporate life |
| 16 Jan 2024 19:30 CET |
HYLORIS | Orphan Drug Designation Granted to PTX-252 by U.S. FDA for the Treatment of Acute Myeloid Leukaemia (AML) | 20103010 Biotechnology | Products and services |
| 16 Jan 2024 19:30 CET |
HYLORIS | La FDA Américaine Accorde la Qualification de Médicament Orphelin au PTX-252 pour le Traitement de la Leucémie Myéloïde Aiguë (LMA) | 20103010 Biotechnology | Products and services |
| 16 Jan 2024 18:00 CET |
INTERVEST OFF-WARE | Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: publication of a transparency notification | 35102030 Office REITs | Change in Capital |
| 16 Jan 2024 18:00 CET |
INTERVEST OFF-WARE | Intervest Offices & Warehouses SA: Communiqué de presse – Persbericht - Press release: publication of a transparency notification | 35102030 Office REITs | Change in Capital |
| 16 Jan 2024 18:00 CET |
INTERVEST OFF-WARE | Intervest Offices & Warehouses NV: Persbericht – Communiqué de presse – Press release: publication of a transparency notification | 35102030 Office REITs | Change in Capital |
| 16 Jan 2024 08:30 CET |
CIE BOIS SAUVAGE | Cie du Bois Sauvage: Buy back of own shares – week from 08/01/2024 to 12/01/2024 | 30202010 Asset Managers and Custodians | Other subject |
| 16 Jan 2024 08:30 CET |
CIE BOIS SAUVAGE | Cie du Bois Sauvage : Rachat d’actions propres – semaine du 08/01/2024 au 12/01/2024 | 30202010 Asset Managers and Custodians | Other subject |
| 16 Jan 2024 08:30 CET |
CIE BOIS SAUVAGE | Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 08/01/2024 tot 12/01/2024 | 30202010 Asset Managers and Custodians | Other subject |
| 16 Jan 2024 08:00 CET |
KBC | KBC Group: Update regarding the KBC Group share buyback programme | 30101010 Banks | Other subject |
| 16 Jan 2024 08:00 CET |
KBC | KBC Groupe: Mise à jour concernant le programme de rachat d’actions propres de KBC Groupe | 30101010 Banks | Other subject |
| 16 Jan 2024 08:00 CET |
KBC | KBC Groep: Update m.b.t. inkoopprogramma van KBC Groep voor eigen aandelen | 30101010 Banks | Other subject |
| 16 Jan 2024 07:30 CET |
GIMV | Gimv neemt als co-leadinvesteerder deel aan een Series C financieringsronde van 30 miljoen EUR bij Onera Health. | 30202010 Asset Managers and Custodians | Other subject |
| 16 Jan 2024 07:30 CET |
GIMV | Gimv acts as co-lead investor in a €30M Series C financing round at Onera Health | 30202010 Asset Managers and Custodians | Other subject |
| 16 Jan 2024 07:30 CET |
GIMV | Gimv acts as co-lead investor in a €30M Series C financing round at Onera Health | 30202010 Asset Managers and Custodians | Other subject |
| 16 Jan 2024 07:30 CET |
GIMV | Gimv acts as co-lead investor in a €30M Series C financing round at Onera Health | 30202010 Asset Managers and Custodians | Other subject |
| 15 Jan 2024 18:09 CET |
GBL | GBL - Transacties op GBL-aandelen 15-01-2024 | 30202000 Diversified Financial Services | Other financial transaction |
| 15 Jan 2024 18:08 CET |
GBL | GBL - Transactions sur actions propres 15-01-2024 | 30202000 Diversified Financial Services | Other financial transaction |
| 15 Jan 2024 18:08 CET |
GBL | GBL - Transactions on GBL shares 15-01-2024 | 30202000 Diversified Financial Services | Other financial transaction |
| 15 Jan 2024 17:59 CET |
CENERGY | Hellenic Cables remporte un contrat pour les parcs éoliens offshore de Bałtyk II et Bałtyk III | 50202010 Electrical Components | News contracts |
| 15 Jan 2024 17:58 CET |
CENERGY | Hellenic Cables awarded a contract for Bałtyk II and Bałtyk III offshore wind farms | 50202010 Electrical Components | News contracts |
| 15 Jan 2024 17:45 CET |
KINEPOLIS GROUP | Update share buyback program (15 January 2024) | 40301010 Entertainment | Corporate life |
| 15 Jan 2024 17:45 CET |
KINEPOLIS GROUP | Mise à jour concernant le programme de rachat d'actions propres (15 janvier 2024) | 40301010 Entertainment | Corporate life |
| 15 Jan 2024 17:45 CET |
KINEPOLIS GROUP | Update inkoopprogramma eigen aandelen (15 januari 2024) | 40301010 Entertainment | Corporate life |
| 15 Jan 2024 08:33 CET |
TITAN CEMENT | Programme de rachats d'actions | 50101030 Cement | Other subject |
| 15 Jan 2024 08:32 CET |
TITAN CEMENT | Share buyback programme | 50101030 Cement | Other subject |
| 15 Jan 2024 07:25 CET |
JENSEN-GROUP | Inkoop eigen aandelen - wekelijkse update | 50204000 Machinery: Industrial | Other subject |
| 15 Jan 2024 07:24 CET |
JENSEN-GROUP | Share buyback – weekly update | 50204000 Machinery: Industrial | Other subject |
| 15 Jan 2024 07:00 CET |
BIOSENIC | BioSenic reaches agreement on a binding term sheet with Phebra PTY Ltd. with respect to the development of the first oral formulation of arsenic troxide for cGvHD treatment | 20103010 Biotechnology | Alliances and agreements |
| 15 Jan 2024 07:00 CET |
BIOSENIC | COMMUNIQUE DE PRESSE – INFORMATION PRIVILIGIEE | 20103010 Biotechnology | Alliances and agreements |
| 15 Jan 2024 07:00 CET |
BIOSENIC | BioSenic S.A. : Transparency notifications received from François Rieger | 20103010 Biotechnology | Other subject |
| 15 Jan 2024 07:00 CET |
BIOSENIC | BioSenic S.A. : Notifications de transparence reçues de la part de François Rieger | 20103010 Biotechnology | Other subject |
| 12 Jan 2024 18:00 CET |
ONTEX GROUP | Transparency Declaration Notification | 45201020 Personal Products | Other subject |
| 12 Jan 2024 18:00 CET |
ONTEX GROUP | Kennisgeving transparantieverklaring | 45201020 Personal Products | Other subject |
| 12 Jan 2024 08:30 CET |
SYENSQO | Introduction of statutory transparency thresholds by Syensqo | 55101000 Diversified Materials | Change in Capital |
| 12 Jan 2024 08:30 CET |
SYENSQO | Introduction de seuils statutaires de transparence par Syensqo | 55101000 Diversified Materials | Change in Capital |
| 12 Jan 2024 08:30 CET |
SYENSQO | Invoering van statutaire transparantiedrempels door Syensqo | 55101000 Diversified Materials | Change in Capital |
| 12 Jan 2024 08:15 CET |
BEKAERT | Bekaert - Update on the Share Buyback Program | 55102010 Iron and Steel | Legal |
| 12 Jan 2024 08:15 CET |
BEKAERT | Bekaert - Mise à jour relative au Programme de Rachat d’Actions | 55102010 Iron and Steel | Legal |
| 12 Jan 2024 08:15 CET |
BEKAERT | Bekaert - Update over het Inkoopprogramma van Eigen Aandelen | 55102010 Iron and Steel | Legal |
| 12 Jan 2024 08:00 CET |
OXURION | Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC | 20103010 Biotechnology | - |
| 11 Jan 2024 18:02 CET |
KINEPOLIS GROUP | Publication of a transparency notification | 40301010 Entertainment | Corporate life |
| 11 Jan 2024 18:02 CET |
KINEPOLIS GROUP | Publication relative à une notification de transparence | 40301010 Entertainment | Corporate life |
| 11 Jan 2024 18:02 CET |
KINEPOLIS GROUP | Openbaarmaking van een transparantiekennisgeving | 40301010 Entertainment | Corporate life |
| 11 Jan 2024 17:40 CET |
ASCENCIO | Ascencio divests among its Belgian portfolio | 35102045 Retail REITs | Mergers, Acquiqitions, Transferts |
| 11 Jan 2024 17:40 CET |
ASCENCIO | Ascencio procède à un arbitrage au sein de son portefeuille belge | 35102045 Retail REITs | Mergers, Acquiqitions, Transferts |
| 11 Jan 2024 17:40 CET |
ASCENCIO | Ascencio voert arbitrage uit in haar belgische portefeuille | 35102045 Retail REITs | Mergers, Acquiqitions, Transferts |